Summary

The global homeopathy market has experienced strong growth and is set to continue expanding, rising from US$6.20 billion to US$19.78 billion between 2020 and 2030. The European market, spearheaded by France, leads the way in homeopathy consumption. North America and Asia lag behind, but are experiencing significant growth, particularly in Asia due to the arrival of major Asian homeopathic laboratories.

The French homeopathy market, despite the challenges posed by the total withdrawal of homeopathic remedies from the social security system 2021, is showing signs of recovery, with the Boiron group announcing a remarkable 17% increase in sales by 2022, after a 50% drop in sales due to the delisting. The importance of homeopathy in France is also evidenced by the high level of consumer use. Exports of homeopathic products from France have remained stable in value terms, totaling 16.4 billion euros in 2022, with the USA and Belgium being important markets, while Germany, Ireland, the USA and Switzerland account for over 50% of French imports.

Despite the delisting of homeopathic treatments and a change in consumer behavior due to the health crisis, complementary care strategies incorporating homeopathy are being explored, and consumer interest in alternative medicine remains strong.

An overview of consumer preferences and industry changes

The French market has long been a bastion for homeopathic remedies. This widespread acceptance testifies to the country's openness to alternative medicines, and has created a solid consumer base that is both loyal and well-informed.

Despite this, the market faced challenges when the government decided to phase out reimbursement for homeopathic treatments, resulting in a significant drop in sales volumes in 2020 and 2021. However, since the delisting, the market has adapted. Leading homeopathic players, such as Laboratoires Boiron and Lehning, have diversified their offering to include probiotics, dietary supplements and health tests for influenza and Covid-19, leading to an increase in sales.

As far as consumer practice is concerned, although homeopathy use in France has plateaued since crossing the 50% user mark, the French continue to believe in the efficacy of homeopathy. The average French user has been taking homeopathic treatments for some twenty years, testifying to a deeply rooted confidence in this form of alternative medicine. However, restrictions linked to the health crisis and de-reimbursements have cast a shadow over the sector, leading to a significant drop in sales for the major companies.

Boiron, in particular, saw its sales fall by around 25% as a result of the delisting. However, the post-crisis period was marked by a gradual recovery, with the company recording a considerable increase in its financial results.

As far as healthcare providers are concerned, around 20,000 general practitioners prescribe homeopathy on a daily basis, but only a minority of them specialize in the field. Despite this, the practice is well integrated into the French healthcare system, with over 50 hospital consultations offering homeopathic treatments. The overall financial implications of homeopathic practices should not be overlooked. It is thought that increased use of homeopathy could reduce reliance on more conventional medicines, which in turn could lower healthcare costs. For specific health problems such as respiratory infections, musculoskeletal pain and psychological disorders, homeopathy could halve or even triple the use of conventional medicines. But the challenges are not without solutions. The market has reacted to the end of social security reimbursements with complementary health insurance companies.

Key players in the homeopathy market - Navigating the landscape beyond conventional medicine

The homeopathy market features a wide variety of established companies and new entrants, each offering unique products and services to meet the growing demand for alternative and complementary medicine. Within this complex tapestry, several key players dominate the scene as leading suppliers of homeopathic remedies, reflecting the market's preference for natural, holistic treatment options.

  • Laboratoires Boiro is a titan in the homeopathic landscape. As the name that resonates most with consumers when it comes to alternative medicine, Boiron's long-standing reputation for quality and its wide range of products have cemented its place at the forefront of the industry. The company has mastered the art of blending tradition and modernity, offering remedies drawn from nature's bounty and formulated according to meticulous processes that underline the brand's commitment to homeopathic principles.

  • Rocal homeopathy, part of the Lehning group, is another benchmark in the field of homeopathic treatments. As a subsidiary dedicated to raising the standard of natural medicine, Rocal's portfolio includes a wide range of preparations for a variety of ailments, from minor health problems to more specific conditions. Building on the strength of its parent company, Rocal targets consumers who trust in the power of nature to heal and maintain well-being.

  • Weleda offers not only homeopathic remedies, but also a wider range of natural health and wellness products. Composed of organic and biodynamic ingredients, Weleda's offering is part of a lifestyle choice, combining the concept of homeopathy with the broader philosophy of holistic health. As such, the brand has gained a following among those who value sustainability and ethical production, as well as the healing prowess of homeopathic medicine.

  • TP Santé (Cegedim Group) and Mon Conseil Pharma (Carte Blanche Partenaires Group) recognized the opportunity to support the sector with innovative solutions. These companies have focused their efforts on developing platforms and partnerships that facilitate access to homeopathic remedies, combining technology with healthcare to create easily navigable systems for patients and pharmacies.

Collectively, these major market players not only reflect homeopathy's enduring popularity among French consumers, but also demonstrate the industry's adaptability and resilience. Whether faced with regulatory challenges or changing market dynamics, these companies have demonstrated an unwavering dedication to offering alternative pathways to health and well-being, contributing to the diversity of homeopathic products in France.

Get all the information you need
to understand this market

Detailed content

Inforamtion

  • Number of pages : 30 pages
  • Format : Digital and PDF versions
  • Last update : 03/10/2023
Update Details

Summary and extracts

1 Market overview

1.1 Definition and scope of study

Homeopathy is a concept created in 1796 by the German physician Samuel Hahnemann. It is based on the idea thata substance that causes a symptom can be used to treat the same symptom of disease. Practitioners of homeopathy believe it works by stimulating the body to heal itself. This practice is based on 3 essential principles[Ministère de la Santé et de la Prévention] :

  • similarity: what can make you ill in high doses can cure you in low doses.
  • infinitesimality : remedies are prepared from active substances called "strains", taken from the plant, mineral and animal kingdoms, using successive Hahnemannian or Korsakovian dilution techniques.
  • the principle of individualization: the approach takes into account not only the symptoms associated with a person's illness, but also their physical and psychological particularities.

The global homeopathy market is estimated to be worth 7.82 billion dollars by 2022. It has grown strongly in recent years and should continue to do so over the next seven years. Europe is currently the leading market for this alternative medicine, followed by North America and Asia. However, it is on the latter continent that sales growth is expected to be most significant, due to the full market entry of the largest Asian homeopathic laboratories. France, meanwhile, is one of the leading consumer countries for homeopathy, with an estimated 77% of French people having used this form of treatment by 2018. [Ipsos]. France is therefore home to a mature market with consumers who are loyal to and educated about homeopathy.

The French market is dominated by long-established players such as the Boiron laboratory, which holds over 50% of market share[Capital], and the Lehning laboratory. Other groups have entered this market more recently, such as the Gilbert group, traditionally specialized in children's health and cosmetics.

Homeopathy has seen its position as an ideal complement to traditional medicine called into question, due to the decision taken in 2019 by Agnès Buzyn, then Minister of Health, to reduce in 2020 and then stop in 2021 the reimbursement of homeopathic treatments by Social Security. Whereas previously many of these treatments were reimbursed at up to 30%, they are now not reimbursed at all from January1, 2021.

As a result, the market suffered a significant drop in volume in 2020 and 2021, which was then partially offset by a rise in treatment prices, and a diversification of activities by major market players (probiotics, dietary supplements, flu tests and Covid-19). Boiron, for example, saw its sales increase by 17% in 2022, after having been divided by 2 between 2019 and 2021. [Challenges]

1.2 Global market

The global homeopathy market is growing rapidly, and is expected to increase by **.*% between **** and ****, from US$*.** billion to US$**.** billion.

sales trends in the homeopathy market World, ****-****, in US$ billion Source: ****

This increase in sales is due to the expansion of this product into more and more markets, whether ...

1.3 Domestic market

In ****, Le Monde estimated the weight of the homeopathy market at *.**% of drug sales by value. That's *** million euros, out of a drug market worth **.* billion euros. We will assume that this share remains unchanged over the ****-**** period.

However, according to the French Pharmaceutical Companies Association (***), sales on the pharmaceutical ...

1.4 International trade

In the CN* nomenclature, homeopathy is included in the category"******** - Medicinal products consisting of mixed or unmixed products, prepared for therapeutic or prophylactic purposes, and put up in measured doses (***)."

However, this data needs to be analyzed with a critical eye, as the category also includes other alternative pharmaceutical products, ...

1.5 Growth slowed by the health crisis and total delisting of reimbursements

While the sector saw its sales slow in **** due to the health crisis, characterized by a sharp decline in winter illnesses, it was further disrupted by the delisting of its products from January *, ****. The study by Boiron, the world leader in homeopathy, is significant in this respect. Its sales fell by ...

2 Demand analysis

2.1 A well-established French consumer practice

Health, at the heart of French people's concerns

At the heart of the **** presidential campaign, **% of French people ranked healthcare as one of the priorities to be addressed by politicians, second only to purchasing power [***].

These figures are the result of a sharp rise in demand for healthcare and medical goods ...

2.2 Popular with the French, but not with healthcare professionals

Homeopathy tops the list of therapies favored by the French [***] The barometer dates from ****, but this gap still exists in ****.

assessment of the gap between patients and doctors on the question of homeopathy France, ****, % Source: ****

This result is significant, even though in ****, **% of French people had confidence in healthcare professionals.[***]

2.3 The French appreciate alternative medicine

Harris interactive conducted a study for Santéclair on "The French and alternative medicine", in ****. The proportion of French people who said they had a good image of alternative medicine was **%, with an over-representation of women and affluent categories. These practices are considered better for the body and the environment than ...

2.4 Homeopathy to reduce healthcare costs

Homeopathy would be in the interest of public health, insofar as the demand for homeopathic products would reduce the demand for heavier drugs. In particular, it could reduce the demand for iatrogenic drugs by a factor of * or *.

For cases of equivalent severity and similar clinical results, homeopathy can be used[***] ...

3 Market structure

3.1 Overview of players

While **,*** general practitioners prescribe homeopathy every day, only *,*** are experts in the field. [***]

According to an Ipsos survey published by Boiron, in ****, those who prescribe the most homeopathy on a daily basis are midwives (***) sell homeopathy on a daily basis.

evaluation of homeopathic practice by healthcare professionals France, ****, % Source: ****

Laboratory involvement ...

3.2 Manufacturing homeopathic products

Homeopathic products come in a variety of forms: granules, syrups and sachets. They are made mainly from plants, but also from minerals, animal matter or chemicals. [***]

Nature of active product by origin France, ****, % Source: ****

These extracts are chosen according to the symptoms they produce, since the homeopathic method consists in "curing ...

4 Offer analysis

4.1 Product offering typology

Average prices for tubes of homeopathic granules are summarized in the following table[***]:

The price of homeopathic granules is now set freely by the laboratories. Prices have been rising steadily since homeopathy was completely de-reimbursed on January *, ****. Some professionals are talking about an increase of up to **% in the price of ...

4.2 Complementary health care offers and services integrating homeopathy

All contracts include homeopathic cover. What's more, ***% of mid-range contracts include a"well-being package". Finally, complementary health insurance covers €*.** per unit of homeopathic medicine prescribed.

In addition, complementary health insurance is supported by a number of services:

Homeo and prevention" webinar for policyholders; Teleconsultation with a homeopathic doctor; Editorial content and ...

4.3 Development of easy management solutions

While homeopathy has been de-reimbursed since January *, ****, three types of players are increasingly calling for a new formula to frame the sector's offerings:

Complementary healthcare ; Patients; Pharmacists. [***]

The main offers already in place are those proposed by the Organismes de Tiers-Payant (***) Cégédim and Carte Blanche Partenaire, with the TP ...

5 Regulations

5.1 Regulations

Article **** of the European Pharmacopoeia stipulates that the name given to a homeopathic preparation is usually the Latin name of the strain used, accompanied by the degree of dilution it has undergone. The French pharmacopoeia lists a number of homeopathic preparations, some examples of which are given below:

Abbies nigra PPH ...

6 Positioning the players

6.1 Segmentation

  • Boiron
  • Weleda
  • Laboratoires Lehning
  • Cegedim
  • Carte Blanche Partenaires
  • Juvamine (Urgo Groupe)

List of charts

  • Sales trends in the homeopathic market
  • Trends in the French homeopathy market
  • Export destination by country for item NC8 30049000
  • Origin of imports by country for item NC8 30049000
  • Trade balance
Show more Hide

All our studies are available online in PDF format

Take a look at an example of our research on another market!

Do you have a question about this study?   +44 238 097 0676

Latest news

Homeopathy: the Boiron family wants to delist the laboratory - 05/07/2023
  • The Boiron family group controls almost 70% of the homeopathic laboratory's capital.
  • The family-owned laboratory employs 2,750 people.
  • The laboratory posted sales of 534 million euros, up 17% year-on-year.
Valérie Lorentz-Poinsot leads the diversification of Boiron, the champion of homeopathy - 06/05/2023
  • In 2022, Boiron's homeopathy business grew by 1%.
  • Growth was driven in particular by North America.
  • Boiron's sales in 2022 will be 534 million euros, an increase of 17%.
  • Two years ago, sales fell by 40%.
  • Restructuring led to the loss of 512 jobs and the closure of thirteen sites. Headcount in France at 1,800.
Boiron: a successful 2022 thanks to innovation. - 05/04/2023
  • - Boiron was founded in 1932 by Jean and Henri Boiron, and is 69.7% owned by the family.
  • - Boiron's sales for 2022 have rebounded by 17.4% compared with 2021, reaching over 534 million euros.
  • - In France, Boiron's sales for 2022 amount to 261 million euros, an increase of 9.4%.
  • - Boiron controls almost 90% of the French homeopathic market.
  • - By 2021, Boiron's sales had fallen to 455.20 million euros, compared with 604 million in 2018.
  • - Sales of products launched by Boiron since 2020 generated 77.6 million euros in 2022.
  • - Boiron has diversified into Covid-19 and flu screening tests, which generated 50 million euros in 2022.
  • - Boiron has 2,769 employees, including 1,811 in France.
  • - In 2022, Boiron obtained 223 marketing authorizations worldwide.
  • - Boiron is present in 50 countries, with sales in North America of €120.5 million in 2022, an increase of 43.7%.
  • - Boiron has diversified into probiotics, dietary supplements and cosmetics, with the acquisition of start-up Abbi for 1.75 million euros in February 2022.
Weleda aims to rejuvenate its brand and accelerate innovation - 28/02/2023
  • The group has stopped production of homeopathic medicines at its Alsace site.
  • The French subsidiary cut 126 jobs
  • France remains the second-largest market behind Germany, accounting for 20% of group sales
  • Weleda relies on a distribution network built around pharmacies, parapharmacies and specialized organic retailers
Medicines: Boiron laboratories saved by Covid tests - 29/01/2023
  • Sales of 534 million euros by 2022, up 17%
  • Agreements with Breton company NG Biotech, for which it assembles and distributes tests from its Messimy plant
  • Agreement with Sino-American laboratory Anbio to market its Covid tests
  • Closure of several preparation and distribution centers across the country
  • In beauty, Boiron acquired Abbi, a start-up, for 1.75 million euros in the first half of 2022
Weleda discontinues homeopathy production in Huningue - 06/07/2022
  • Weleda discontinues the production of homeopathic products at the Huningue site
  • 127 of 290 jobs are under threat
  • The site is running at 30% of its capacity.
  • Production will be discontinued in France and continued in Germany.
  • The Group is looking for a buyer, production will cease in 2023
  • The Group's turnover in 2021 amounted to EUR 60 million.
  • Weleda's turnover has fallen by 36% in four years

Companies quoted in this study

This study contains a complete overview of the companies in the market, with the latest figures and news for each company. :

Boiron
Weleda
Laboratoires Lehning
Cegedim
Carte Blanche Partenaires
Juvamine (Urgo Groupe)

Choosing this study means :

Access to more than 35 hours of work

Our studies are the result of over 35 hours of research and analysis. Using our studies allows you to devote more time and added value to your projects.

Benefit from 6 years' experience and over 1,500 industry reports already produced

Our expertise enables us to produce comprehensive studies in all sectors, including niche and emerging markets.

Our know-how and methodology enable us to produce reports that offer unique value for money.

Access to several thousand articles and paid-for data

Businesscoot has access to all the paid economic press as well as exclusive databases to carry out its market research (over 30,000 articles and private sources).

To enhance our research, our analysts also use web indicators (semrush, trends, etc.) to identify market trends and company strategies. (Consult our paying sources)

Guaranteed support after your purchase

A team dedicated to after-sales service, to guarantee you a high level of satisfaction. +44 238 097 0676

A digital format designed for our users

Not only do you have access to a PDF, but also to a digital version designed for our customers. This version gives you access to sources, data in Excel format and graphics. The content of the study can therefore be easily retrieved and adapted for your specific needs.

Our offers :

the homeopathy market | France

89 €
  • What are the figures on the size and growth of the market?
  • What is driving the growth of the market and its evolution?
  • What is the positioning of companies in the value chain?
  • Data from several dozen databases

Pack 5 études (-15%) France

75.6 € / study
378 € instead of 445 € -15%
  • 5 études au prix de 75,6€HT par étude à choisir parmi nos 800 titres sur le catalogue France pendant 12 mois
  • Conservez -15% sur les études supplémentaires achetées
  • Choisissez le remboursement des crédits non consommés au terme des 12 mois (durée du pack)

Consultez les conditions du pack et de remboursement des crédits non consommés.

Updates

Our customer references

They have consulted our studies Discover the opinions (+500)

Malcolm Vincent
Linkedin logo

Malcolm Vincent

Astoria Finance

Gregoire de Castelnau
Linkedin logo

Gregoire de Castelnau

Stags Participations

Timothé Huignard
Linkedin logo

Timothé Huignard

PWC

Paul-Alexis Kebabtchieff
Linkedin logo

Paul-Alexis Kebabtchieff

BCG

Aymeric Granet
Linkedin logo

Aymeric Granet

Publicis Consultant

interviews & case studies All interviews and case studies (45)

La pépite Interview

BFM Business

Paul-Alexis Kebabtchieff

Boston Consulting Group

Marie Guibart

Kea Partners

Elaine, Durand

Crédit Agricole, Information & Veille

Philippe Dilasser

Initiative & Finance

Anne Baudry

Metro

Amaury Wernert

Kroll (Duff & Phelps)

Smart Leaders Interview

B-Smart

Do you have a question ?
Our team is at your disposal at   +44 238 097 0676